Senda Biosciences
Latest round
- Series C
Last raised
- Apr 2022
Total raised
- $192M
Investors
- 12
About Senda Biosciences
Founded in 2017 and based in Massachusetts, US, Senda Biosciences, Inc. operates as a biotechnology company that creates novel treatments for human disease. The company was co-founded by David Kolesky, David Berry, and Ignacio Martinez. Senda Biosciences is a company that is harnessing the molecular interactions that have evolved over millennia between humans, plants, and bacteria to develop new types of medicines. The company offers its Intersystems Biology that focuses on molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. It builds research on the microbiome, omics, and big data, and traditional taxonomic descriptions to delineate interspecies interactions using techniques in machine learning and computational biology. The company's discovery platform identifies, quantifies, and locates molecular connections with hundreds of times the diversity of traditional stool-based sampling methods. The company plans to develop its platform and therapeutic programs into clinical trials.
Who invested in Senda Biosciences
12 investors across 3 rounds
See all investors in Senda Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Senda Biosciences
Who invested in Senda Biosciences?
Senda Biosciences has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Senda Biosciences raised?
Senda Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Senda Biosciences last raise money?
Senda Biosciences's most recent round on record is a Series C, in Apr 2022.
What does Senda Biosciences do?
Founded in 2017 and based in Massachusetts, US, Senda Biosciences, Inc.
Where is Senda Biosciences headquartered?
Senda Biosciences is headquartered in Cambridge, US.
Which VCs invest in companies like Senda Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Senda Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Senda Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.